Skip to content

Early application of combined Chinese medicine and Western medicine to treat severe virus pneumonia :a randomized controlled clinical trial

Early application of combined Chinese medicine and Western medicine to treat severe virus pneumonia :a randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015930
Enrollment
Unknown
Registered
2018-04-29
Start date
2018-04-20
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral pneumonia

Interventions

western medicine treatment:Standard western medicine treatment
combined Chinese and western medicine treatment:Qingwen Tang and standard western medicine treatment

Sponsors

Shanghai Jiaotong University Medical College, Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with 1. Acute upper respiratory symptoms, fever, headache, muscle pain, pharyngeal pain and other clinical manifestations; 2. Chest radiographic examination revealed new patchy infiltration, leaf/segment consolidation, ground-glass opacities or interstitial changes, with or without pleural effusion; 3. Pharyngeal swab, sputum, bronchoalveolar lavage, lung or other biopsy materials showed virus nucleic acid test positive; 4. meet the diagnostic criteria of severe pneumonia: meet the following 1 primary criteria or 3 secondary criteria; primary criteria: Need invasive mechanical ventilation; Septic shock after active fluid resuscitation still requires vasoactive drug therapy. Secondary criteria: 1. Breath rates?30/min 2 oxygenation index ?250; 3. Multiple lobes infiltration; 4. Consciousness disorder and (or) disorientation; 5. Blood urea nitrogen? 7.14mmol/L; 6.Systolic pressure < 90mmHg and needs active liquid resuscitation.

Exclusion criteria

Exclusion criteria: 1. aged < 18 years; 2. pregnancy; 3. received glucocorticoid therapy in the last 3 months; 4. clearly diagnose the following diseases: (1) acute cerebrovascular disease; (2) acute coronary syndrome; (3) acute pulmonary edema; (4) acute asthma attack; (5) severe arrhythmia (as primary disease); (6) epilepsy; (7) drug poisoning; (8) burns or trauma; 5. the hemodynamic instability caused by the active hemorrhage of digestive tract; 6. clear immunodeficiency diseases or other clear immunosuppressive states; 7. need immediate surgery; 8. AIDS; 9. incomplete acceptance of standard treatment programmes.

Design outcomes

Primary

MeasureTime frame
ICU mortality in 28 days;

Secondary

MeasureTime frame
Basic vital signs;The overall severity of the disease;Infection related indicators;inflammatory factor;immunity index;Application of other therapeutic measures;syndrome of Chinese medicine;

Countries

China

Contacts

Public ContactLiu Jialin

Shanghai Jiaotong University Medical College, Ruijin Hospital

liujialin77@163.com+86 13916321955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026